Pacira BioSciences, Inc. (NASDAQ: PCRX) presents an intriguing opportunity for investors eyeing growth within the healthcare sector, particularly in specialty and generic drug manufacturing. With a market cap of $1.2..
Phreesia, Inc. (PHR), a key player in the healthcare industry’s burgeoning health information services sector, is attracting significant investor interest with its promising growth trajectory and a hefty potential upside..
Artivion, Inc. (AORT), a prominent player in the healthcare sector under the medical devices industry, is capturing investor attention with a potential upside of 13.98%. Headquartered in Kennesaw, Georgia, Artivion..
QuidelOrtho Corporation (NASDAQ: QDEL), a prominent player in the healthcare sector, is capturing investor attention with its expansive range of diagnostic solutions and an enticing potential upside of 29.62%. With..
Investors with a keen eye on the healthcare sector should take note of Biohaven Ltd. (NASDAQ: BHVN), a biotechnology company that has captured attention with its innovative approach to developing..
Azenta, Inc. (NASDAQ: AZTA), a prominent name in the healthcare sector, specializes in medical instruments and supplies. With a market capitalization of $1.61 billion, the company is a key player..
AdaptHealth Corp. (NASDAQ: AHCO) stands out in the healthcare sector with its robust portfolio of home medical equipment and related services, including sleep therapy, diabetes management, and chronic care solutions...
Aurinia Pharmaceuticals Inc. (NASDAQ: AUPH) stands out in the biotechnology sector, particularly for investors seeking exposure to a company focused on addressing high unmet medical needs in autoimmune diseases. With..
Astrana Health Inc. (ASTH), a prominent player in the healthcare sector, is drawing significant attention from investors eyeing substantial growth opportunities. With its headquarters nestled in Alhambra, California, Astrana operates..
For individual investors eyeing opportunities in the biotechnology sector, Crinetics Pharmaceuticals, Inc. (NASDAQ: CRNX) presents a compelling case. This clinical-stage pharmaceutical company, based in San Diego, California, specializes in developing..
Structure Therapeutics Inc. (NASDAQ: GPCR), a clinical-stage biopharmaceutical company, has captured the attention of investors with its promising portfolio of oral small molecule therapeutics targeting chronic diseases. Headquartered in South..
Bausch Health Companies Inc. (NYSE: BHC), a major player in the healthcare sector specializing in drug manufacturing, is capturing investor interest with its notable forward P/E ratio of 1.65. This..
Amneal Pharmaceuticals, Inc. (AMRX) is garnering significant attention from investors in the healthcare sector, especially given its notable potential upside of 10.75%. As a key player in the drug manufacturing..
CONMED Corporation (NASDAQ: CNMD), a distinguished name in the healthcare sector, specializes in the development and distribution of innovative medical devices and equipment tailored for surgical procedures. With a market..
GRAIL, Inc. (GRAL) has garnered significant attention in the healthcare diagnostics and research industry with its innovative multi-cancer early detection testing services. Based in Menlo Park, California, GRAIL is making..
MannKind Corporation (NASDAQ: MNKD), a biopharmaceutical company, stands out in the biotechnology sector with its strategic focus on developing and commercializing therapeutic products for endocrine and orphan lung diseases. Headquartered..
For investors eyeing opportunities in the healthcare sector, Acadia Healthcare Company, Inc. (NASDAQ: ACHC) presents a compelling case with its significant potential upside. With a market capitalization of $1.31 billion,..
Janux Therapeutics, Inc. (NASDAQ: JANX) is making waves in the biotechnology sector with its innovative approach to cancer treatment. The company, headquartered in San Diego, California, stands out with its..
Travere Therapeutics, Inc. (NASDAQ: TVTX) stands out in the biotechnology sector with its focus on developing therapies for rare kidney and metabolic diseases. As a biopharmaceutical company, Travere Therapeutics leverages..
